Bruker Share Holder Equity 2012-2026 | BRKR
Bruker share holder equity from 2012 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
- Bruker share holder equity for the quarter ending March 31, 2026 was $2.450B, a 34.21% increase year-over-year.
- Bruker share holder equity for 2024 was $1.797B, a 28.86% increase from 2023.
- Bruker share holder equity for 2023 was $1.395B, a 23.89% increase from 2022.
- Bruker share holder equity for 2022 was $1.126B, a 3.79% increase from 2021.
|
Bruker Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $1,797 |
| 2023 | $1,395 |
| 2022 | $1,126 |
| 2021 | $1,085 |
| 2020 | $974 |
| 2019 | $917 |
| 2018 | $905 |
| 2017 | $734 |
| 2016 | $693 |
| 2015 | $733 |
| 2014 | $772 |
| 2013 | $850 |
| 2012 | $710 |
| 2011 | $625 |
|
Bruker Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $2,450 |
| 2025-06-30 | $1,819 |
| 2025-03-31 | $1,833 |
| 2024-12-31 | $1,797 |
| 2024-09-30 | $1,825 |
| 2024-06-30 | $1,807 |
| 2024-03-31 | $1,433 |
| 2023-12-31 | $1,395 |
| 2023-09-30 | $1,227 |
| 2023-06-30 | $1,251 |
| 2023-03-31 | $1,199 |
| 2022-12-31 | $1,126 |
| 2022-09-30 | $948 |
| 2022-06-30 | $984 |
| 2022-03-31 | $1,031 |
| 2021-12-31 | $1,085 |
| 2021-09-30 | $1,090 |
| 2021-06-30 | $1,015 |
| 2021-03-31 | $982 |
| 2020-12-31 | $974 |
| 2020-09-30 | $963 |
| 2020-06-30 | $907 |
| 2020-03-31 | $925 |
| 2019-12-31 | $917 |
| 2019-09-30 | $855 |
| 2019-06-30 | $870 |
| 2019-03-31 | $922 |
| 2018-12-31 | $905 |
| 2018-09-30 | $825 |
| 2018-06-30 | $785 |
| 2018-03-31 | $790 |
| 2017-12-31 | $734 |
| 2017-09-30 | $740 |
| 2017-06-30 | $763 |
| 2017-03-31 | $732 |
| 2016-12-31 | $693 |
| 2016-09-30 | $701 |
| 2016-06-30 | $670 |
| 2016-03-31 | $709 |
| 2015-12-31 | $733 |
| 2015-09-30 | $768 |
| 2015-06-30 | $768 |
| 2015-03-31 | $722 |
| 2014-12-31 | $772 |
| 2014-09-30 | $813 |
| 2014-06-30 | $885 |
| 2014-03-31 | $868 |
| 2013-12-31 | $850 |
| 2013-09-30 | $781 |
| 2013-06-30 | $723 |
| 2013-03-31 | $693 |
| 2012-12-31 | $710 |
| 2012-09-30 | $696 |
| 2012-06-30 | $642 |
| 2012-03-31 | $662 |
| 2011-12-31 | $625 |
| 2011-09-30 | $603 |
| 2011-06-30 | $631 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |